Our Insights

PSA’s Daniel Skeens discusses pre-IPO, pre-M&A and other pre-transaction diligence and answers our questions about best practices in identifying off-balance sheet risks. Daniel describes the value of adopting an investigative approach to due diligence to build a coherent and comprehensive picture of a counterparty prior to finalizing a significant transaction.

PSA’s Corruption Risk Profiles aggregate the best available data on corruption, rule of law, and FCPA enforcement. This is combined PSA’s with on-the-ground insights into information accessibility in key markets to provide a snapshot of local corruption risks and uncertainties impacting risk assessments.

In this episode of the Better Intelligence Podcast, PSA’s Michael Olver speaks with Charles Duross, who spent seven years at the DOJ’s FCPA unit before entering private practice to counsel clients on FCPA matters. Charles, whom the Washington Post has dubbed “Mr. FCPA,” provides Michael and guest co-host Katayune Ehsani...

The Better Intelligence Podcast welcomes Katayune Ehsani for a discussion about day-to-day challenges in corporate investigations and compliance. Katayune shares insights earned from her experiences with corporate investigations as an attorney and investigator working on fraud, corruption, and conflict of interest cases in Middle East, Russia/CIS, Turkey, and Africa.

Originally a tool for investors, ESG is increasingly used by other corporate stakeholders to evaluate risks associated with sustainability, human rights, and governance among business partners. In this episode, Sarah Carpenter of Assent Compliance talks with PSA’s Michael Olver about how ESG can be leveraged by risk management programs to achieve a...

Latin American countries have presented significant FCPA risks in recent years. Of the 82 FCPA cases settled in the last five years, 31 have involved the top five Latin American economies: Argentina, Brazil, Chile, Colombia, and Mexico.  PSA’s new regional FCPA Risk Overview provides a data-driven survey of corruption risks and FCPA enforcement...

Healthcare is among the most penalized sectors when it comes to FCPA enforcement. Pharmaceutical, medical supply, and medical technology companies face extensive exposure to government officials due to high volumes of sales to government end-users and a heightened need for regulatory approvals. In addition to these typical FCPA risk factors,...